RT Journal Article SR Electronic T1 Determinants of exposure to Aedes mosquitoes: a comprehensive geospatial analysis in peri-urban Cambodia JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.09.12.22278870 DO 10.1101/2022.09.12.22278870 A1 Parker, Daniel M. A1 Medina, Catalina A1 Bohl, Jennifer A1 Lon, Chanthap A1 Chea, Sophana A1 Lay, Sreyngim A1 Kong, Dara A1 Nhek, Sreynik A1 Man, Somnang A1 Doehl, Johannes S. P. A1 Leang, Rithea A1 Kry, Hok A1 Rekol, Huy A1 Oliveira, Fabiano A1 Minin, Vladimir A1 Manning, Jessica E. YR 2022 UL http://medrxiv.org/content/early/2022/09/14/2022.09.12.22278870.abstract AB Aedes mosquitoes are some of the most important and globally expansive vectors of disease. Public health efforts are largely focused on prevention of human-vector contact. A range of entomological indices are used to measure risk of disease, though with conflicting results (i.e. larval or adult abundance does not always predict risk of disease). There is a growing interest in the development and use of biomarkers for exposure to mosquito saliva, including for Aedes spp, as a proxy for disease risk. In this study, we conduct a comprehensive geostatistical analysis of exposure to Aedes mosquito bites among a pediatric cohort in a peri-urban setting endemic to dengue, Zika, and chikungunya viruses. We use demographic, household, and environmental variables (the flooding index (NFI), land type, and proximity to a river) in a Bayesian geostatistical model to predict areas of exposure to Aedes aegypti bites. We found that hotspots of exposure to Ae. aegypti salivary gland extract (SGE) were relatively small (< 500m and sometimes < 250m) and stable across the two-year study period. Age was negatively associated with antibody responses to Ae. aegypti SGE. Those living in agricultural settings had lower antibody responses than those living in urban settings, whereas those living near recent surface water accumulation were more likely to have higher antibody responses. Finally, we incorporated measures of larval and adult density in our geostatistical models and found that they did not show associations with antibody responses to Ae. aegypti SGE after controlling for other covariates in the model. Our results indicate that targeted house- or neighborhood-focused interventions may be appropriate for vector control in this setting. Further, demographic and environmental factors more capably predicted exposure to Ae. aegypti mosquitoes than commonly used entomological indices. Keywords: Aedes; saliva; geostatistical; environmental; dengue fever; Zika; chikungunyaCompeting Interest StatementThe authors have declared no competing interest.Funding StatementFunding for this work came from the Division of Intramural Research at the National Institute of Allergy and Infectious Diseases and partially from the National Cancer Institute (contract number 75N910D00024, task order number 75N91019F00130 to A. M.).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the institutional review boards at the US National Institutes of Health and the National Ethics Committee on Human Research in Cambodia. The guardians of all pediatric participants provided signed informed consent to participate in the study. The clinical protocol is available at https://clinicaltrials.gov/ct2/show/NCT03534245.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained within the manuscript